Shudong Wang
25Patents
7h-index
36Co-inventors
69Inventor score
Filing activity: Jul 2, 1999 → Feb 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6472507B1 | Carrier based drug delivery system | Human Necessities | 34 | Expired |
| US6531479B2 | Anti-cancer compounds | Chemistry; Metallurgy | 24 | Expired |
| US6699854B2 | Anti-cancer compounds | Chemistry; Metallurgy | 20 | Expired |
| US7432260B2 | Pyrimidine compounds | Chemistry; Metallurgy | 10 | Expired |
| US7337731B2 | Conjoined folding table | Human Necessities | 9 | Expired |
| US7153931B1 | Transport vectors | Chemistry; Metallurgy | 9 | Expired |
| US7897605B2 | Pyrimidine compounds | Chemistry; Metallurgy | 9 | Active |
| US8309550B2 | Kinase inhibitors and their use as pharmaceutical agents | Chemistry; Metallurgy | 7 | Active |
| US7388015B2 | N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds | Human Necessities | 6 | Expired |
| US6992169B2 | Carrier based drug delivery system | Human Necessities | 6 | Expired |
| US7576091B2 | Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases | Human Necessities | 5 | Expired |
| US7902361B2 | Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy | Chemistry; Metallurgy | 4 | Active |
| US7262202B2 | Inhibitors of cyclin dependent kinases as anti-cancer agent | Human Necessities | 4 | Expired |
| US7427627B2 | N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds | Human Necessities | 2 | Expired |
| US9492811B2 | Zeolite and redox oxide combined catalyst body | Chemistry; Metallurgy | 2 | Active |
| US11325900B2 | 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US11111245B2 | Derivatives of N-cycloalkyl/heterocycloalkyl-4-(imidazo[1,2-a]pyridine)pyrimidin-2-amine as therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US11566024B2 | Tartrate of selective CDK9 inhibitor and crystal form thereof | Chemistry; Metallurgy | 0 | Active |
| US8829003B2 | Compounds for treating proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US10188985B2 | Zeolite and redox oxide combined catalyst body | Chemistry; Metallurgy | 0 | Active |
| US9062039B2 | Therapeutic compounds | Human Necessities | 0 | Active |
| US12398132B2 | Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| USRE49850E1 | N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds | General | 0 | Active |
| US11970491B2 | N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds | Human Necessities | 0 | Active |
| US10479785B2 | N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.